These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30776364)

  • 1. Pulmonary Edema Following Initiation of Parenteral Prostacyclin Therapy for Pulmonary Arterial Hypertension: A Retrospective Study.
    Khan NA; Khan RA; Tonelli AR; Highland KB; Chaisson NF; Jacob M; Renapurkar R; Dweik RA; Heresi GA
    Chest; 2019 Jul; 156(1):45-52. PubMed ID: 30776364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from parenteral to inhaled prostacyclin therapy in pulmonary arterial hypertension.
    Ataya A; Somoracki A; Cope J; Alnuaimat H
    Pulm Pharmacol Ther; 2016 Oct; 40():39-43. PubMed ID: 27470680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient Initiation of Oral Treprostinil in an Academic Medical System.
    Hohlfelder B; Tonelli AR; Heresi GA; Bair N; Rahaghi FF; Bauer SR
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):547-553. PubMed ID: 32424651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.
    Parikh KS; Doerfler S; Shelburne N; Kennedy K; Whitson J; Dahhan T; Fortin T; Rajagopal S
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):299-304. PubMed ID: 31934912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.
    Menon AA; Sahay S; Braverman LE; Farber HW
    Lung; 2019 Dec; 197(6):761-768. PubMed ID: 31696306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
    Boucly A; Savale L; Jaïs X; Bauer F; Bergot E; Bertoletti L; Beurnier A; Bourdin A; Bouvaist H; Bulifon S; Chabanne C; Chaouat A; Cottin V; Dauphin C; Degano B; De Groote P; Favrolt N; Feng Y; Horeau-Langlard D; Jevnikar M; Jutant EM; Liang Z; Magro P; Mauran P; Moceri P; Mornex JF; Palat S; Parent F; Picard F; Pichon J; Poubeau P; Prévot G; Renard S; Reynaud-Gaubert M; Riou M; Roblot P; Sanchez O; Seferian A; Tromeur C; Weatherald J; Simonneau G; Montani D; Humbert M; Sitbon O
    Am J Respir Crit Care Med; 2021 Oct; 204(7):842-854. PubMed ID: 34185620
    [No Abstract]   [Full Text] [Related]  

  • 7. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease.
    Palmer SM; Robinson LJ; Wang A; Gossage JR; Bashore T; Tapson VF
    Chest; 1998 Jan; 113(1):237-40. PubMed ID: 9440597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis.
    Humbert M; Maître S; Capron F; Rain B; Musset D; Simonneau G
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1681-5. PubMed ID: 9603154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoprostenol for the treatment of pulmonary arterial hypertension.
    Cristo Ropero MJ; Cruz-Utrilla A; Escribano-Subias MP
    Expert Rev Clin Pharmacol; 2021 Aug; 14(8):1005-1013. PubMed ID: 34030557
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension.
    Olsson KM; Richter MJ; Kamp JC; Gall H; Heine A; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
    J Heart Lung Transplant; 2019 Jul; 38(7):748-756. PubMed ID: 31128966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Titration of Intravenous Treprostinil to Treat Severe Pulmonary Arterial Hypertension Postpartum: A Retrospective Observational Case Series Study.
    Wang T; Lu J; Li Q; Chen Y; Ye Q; Gao J; Yang D; Zhao L; Huang J; Zhang J
    Anesth Analg; 2019 Dec; 129(6):1607-1612. PubMed ID: 31743181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Perioperative Administration of Treprostinil in Infants with Non-restrictive Ventricular Septal Defect and Severe Pulmonary Arterial Hypertension.
    Huang ST; Xu N; Sun KP; Chen LW; Cao H; Chen Q
    Pediatr Cardiol; 2020 Oct; 41(7):1334-1339. PubMed ID: 32468125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.
    Thomas IC; Glassner-Kolmin C; Gomberg-Maitland M
    Int J Cardiol; 2013 Oct; 168(4):4117-21. PubMed ID: 23890862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin Therapy: An Observational Study.
    Shah T; Manthena P; Patel C; Chuah A; Hardin EA; Torres F; Bartolome SD; Chin KM
    Chest; 2022 Sep; 162(3):669-683. PubMed ID: 35460641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoprostenol sodium for treatment of pulmonary arterial hypertension.
    Saito Y; Nakamura K; Akagi S; Sarashina T; Ejiri K; Miura A; Ogawa A; Matsubara H; Ito H
    Vasc Health Risk Manag; 2015; 11():265-70. PubMed ID: 25999730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid initiation of intravenous epoprostenol infusion is the favored option in patients with advanced pulmonary arterial hypertension.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Kuwana M; Fukuda K; Satoh T
    PLoS One; 2015; 10(4):e0121894. PubMed ID: 25844932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension.
    Suleman N; Frost AE
    Chest; 2004 Sep; 126(3):808-15. PubMed ID: 15364760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Rhee RL; Gabler NB; Praestgaard A; Merkel PA; Kawut SM
    Arthritis Rheumatol; 2015 Sep; 67(9):2457-65. PubMed ID: 26016953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.
    McLaughlin VV; Palevsky HI
    Clin Chest Med; 2013 Dec; 34(4):825-40. PubMed ID: 24267307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.